Evidence map›Paper›PMID 32971277›Full record

ArticleContemporary clinical trials2020

Practical telehealth to improve control and engagement for patients with clinic-refractory diabetes mellitus (PRACTICE-DM): Protocol and baseline data for a randomized trial.

Elizabeth A Kobe, David Edelman, Phillip E Tarkington, Hayden B Bosworth, Matthew L Maciejewski, Karen Steinhauser, Amy S Jeffreys, Cynthia J Coffman, Valerie A Smith, Elizabeth M Strawbridge and 18 more

Registry-linked trialOpen access · greenAbstract readClinical Trial Protocol
In one paragraph

Article in Contemporary clinical trials, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03520413 (Practical Telemedicine to Improve Control and Engagement for Veterans With Clinic-Refractory Diabetes Mellitus), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03520413 nacompletednot on this map

Practical Telemedicine to Improve Control and Engagement for Veterans With Clinic-Refractory Diabetes Mellitus (PRACTICE-DM)

TypeinterventionalSponsorVA Office of Research and DevelopmentRan2018 to 2021Enrolled200ConditionsTelemedicineArmsPRACTICE-DM, Standard VA Home Telehealth
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Evaluating Therapeutic Inertia in Two Telehealth Interventions for Type 2 Diabetes: Secondary Analyses of a Randomized Trial.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2024
    Trial
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 5 institutions in 1 country.

Elizabeth A KobeDuke University School of Medicine, Durham, NC, United States of America.
David EdelmanDurham Veterans Affairs Center of Innovation to Accelerate Discovery and Practice Change (ADAPT), Durham, NC, United States of America; Division of General Internal Medicine, Department of Medicine, Duke University School of Medicine, Durham, NC, United States of America.
Phillip E TarkingtonCentral Virginia Veterans Affairs Health Care System, Richmond, VA, United States of America.
Hayden B BosworthDurham Veterans Affairs Center of Innovation to Accelerate Discovery and Practice Change (ADAPT), Durham, NC, United States of America; Division of General Internal Medicine, Department of Medicine, Duke University School of Medicine, Durham, NC, United States of America; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, United States of America.
Matthew L MaciejewskiDurham Veterans Affairs Center of Innovation to Accelerate Discovery and Practice Change (ADAPT), Durham, NC, United States of America; Division of General Internal Medicine, Department of Medicine, Duke University School of Medicine, Durham, NC, United States of America; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, United States of America.
Karen SteinhauserDurham Veterans Affairs Center of Innovation to Accelerate Discovery and Practice Change (ADAPT), Durham, NC, United States of America.
Amy S JeffreysDurham Veterans Affairs Center of Innovation to Accelerate Discovery and Practice Change (ADAPT), Durham, NC, United States of America.
Cynthia J CoffmanDurham Veterans Affairs Center of Innovation to Accelerate Discovery and Practice Change (ADAPT), Durham, NC, United States of America; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, United States of America.
Valerie A SmithDurham Veterans Affairs Center of Innovation to Accelerate Discovery and Practice Change (ADAPT), Durham, NC, United States of America; Division of General Internal Medicine, Department of Medicine, Duke University School of Medicine, Durham, NC, United States of America; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, United States of America.
Elizabeth M StrawbridgeDurham Veterans Affairs Center of Innovation to Accelerate Discovery and Practice Change (ADAPT), Durham, NC, United States of America.
Steven T SzaboDurham Veterans Affairs Health Care System, Durham, NC, United States of America; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, United States of America; VA Mid-Atlantic Mental Illness, Research, Education and Clinical Center, Durham, NC, United States of America.
Shivan DesaiCentral Virginia Veterans Affairs Health Care System, Richmond, VA, United States of America.
Mary P GarrettDurham Veterans Affairs Health Care System, Durham, NC, United States of America.
Theresa C WilmotDurham Veterans Affairs Health Care System, Durham, NC, United States of America.
Teresa J MarcanoCentral Virginia Veterans Affairs Health Care System, Richmond, VA, United States of America.
Donna L OverbyCentral Virginia Veterans Affairs Health Care System, Richmond, VA, United States of America.
Glenda A TisdaleCentral Virginia Veterans Affairs Health Care System, Richmond, VA, United States of America.
Melissa DurkeeDepartment of Pharmacy, Durham Veterans Affairs Health Care System, Durham, NC, United States of America.
Susan BullardDepartment of Pharmacy, Durham Veterans Affairs Health Care System, Durham, NC, United States of America.
Moahad S DarGreenville VA Health Care Center, Greenville, NC, United States of America; Division of Endocrinology, Department of Medicine, Brody School of Medicine at East Carolina University, Greenville, NC, United States of America.
Amy C MundyCentral Virginia Veterans Affairs Health Care System, Richmond, VA, United States of America.
Janette HinerCentral Virginia Veterans Affairs Health Care System, Richmond, VA, United States of America.
Sonja K FredricksonCentral Virginia Veterans Affairs Health Care System, Richmond, VA, United States of America.
Nadya T Majette ElliottDurham Veterans Affairs Center of Innovation to Accelerate Discovery and Practice Change (ADAPT), Durham, NC, United States of America.
Teresa HowardDurham Veterans Affairs Center of Innovation to Accelerate Discovery and Practice Change (ADAPT), Durham, NC, United States of America.
Deborah H JeterCentral Virginia Veterans Affairs Health Care System, Richmond, VA, United States of America.
Susanne DanusDurham Veterans Affairs Center of Innovation to Accelerate Discovery and Practice Change (ADAPT), Durham, NC, United States of America.
Matthew J CrowleyDurham Veterans Affairs Center of Innovation to Accelerate Discovery and Practice Change (ADAPT), Durham, NC, United States of America; Division of Endocrinology, Department of Medicine, Duke University School of Medicine, Durham, NC, United States of America. Electronic address: matthew.crowley@duke.edu.
Durham VA Medical Center · USVA Central California Health Care System · USDurham VA Health Care System · USDuke University · USPrisma Health · US

Funding

NRSA Training CoreTL1TR002555 · NCATS · DUKE UNIVERSITY · PI EDELMAN, DAVID · 2018 to 2022
$3.7M
Neurosteroids in PTSD - Biomarkers to TherapeuticsIK2CX001397 · VA · DURHAM VA MEDICAL CENTER · PI SZABO, STEVEN · 2018 to 2021
–
HSR&D Senior Research Career Scientist AwardIK6HX003161 · VA · DURHAM VA MEDICAL CENTER · PI Hayden B Bosworth · 2020 to 2026
–
CSRD VA IK2 CX001397HSRD VA CDA 13-261HSRD VA CIN 13-410HSRD VA I01 HX002339HSRD VA IK6 HX003161HSRD VA RCS 08-027NCATS NIH HHS TL1 TR002555
6 · The paper itself

Abstract

backgroundPersistent poorly-controlled type 2 diabetes mellitus (PPDM), or maintenance of a hemoglobin A1c (HbA1c) ≥8.5% despite receiving clinic-based diabetes care, contributes disproportionately to the national diabetes burden. Comprehensive telehealth interventions may help ameliorate PPDM, but existing approaches have rarely been designed with clinical implementation in mind, limiting use in routine practice. We describe a study testing a novel telehealth intervention that comprehensively targets clinic-refractory PPDM, and was explicitly developed for practical delivery using existing Veterans Health Administration (VHA) clinical infrastructure.

methodsPractical Telehealth to Improve Control and Engagement for Patients with Clinic-Refractory Diabetes Mellitus (PRACTICE-DM) is an ongoing randomized controlled trial comparing two 12-month interventions: 1) standard VHA Home Telehealth (HT) telemonitoring/care coordination; or 2) the PRACTICE-DM intervention, a comprehensive HT-delivered intervention combining telemonitoring, self-management support, diet/activity support, medication management, and depression management. The primary outcome is HbA1c. Secondary outcomes include diabetes distress, self-care, self-efficacy, weight, depressive symptoms, implementation barriers/facilitators, and costs. We hypothesize that the PRACTICE-DM intervention will reduce HbA1c by >0.6% versus standard HT over 12 months.

resultsEnrollment for this ongoing trial concluded in January 2020; 200 patients were randomized (99 to standard HT and 101 to the PRACTICE-DM intervention). The cohort has a mean age of 58 and is 23% female and 72% African American. Mean baseline HbA1c and BMI were 10.2% and 34.8 kg/m

conclusionsBecause it comprehensively targets factors underlying PPDM using existing clinical infrastructure, the PRACTICE-DM intervention may be well suited to lower the complications and costs of PPDM in routine practice.

Indexed as

Diabetes Mellitus, Type 2TelemedicineFemaleGlycated HemoglobinHumansMaleRandomized Controlled Trials as TopicSelf CareSelf EfficacyGlycated HemoglobinComparative effectivenessHealth services researchPoorly controlled diabetesTelehealth intervention

Identifiers

PMID32971277
PMCPMC7505207
OpenAlexW3088969690

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.